Effectiveness and Safety of 3 Fixed Doses (25 mg eq., 100 mg eq., and 150 mg eq.) of Paliperidone Palmitate in Patients With Schizophrenia
type: MedicalStudy
description: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose Response Study to Evaluate the Efficacy and Safety of 3 Fixed Doses (25 mg eq., 100 mg eq., and 150 mg eq.) of Paliperidone Palmitate in Subjects With Schizophrenia
status: COMPLETED
study design: INTERVENTIONAL
phase: PHASE3
start date: 2007-03
end date: 2008-03
license: https://creativecommons.org/publicdomain/zero/1.0/
source: https://clinicaltrials.gov/study/NCT00590577
source organization: US National Library of Medicine
publisher: AI Analytics
sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
study subject: Schizophrenia
keywords: PHASE3
keywords: INTERVENTIONAL
keywords: COMPLETED
keywords: Schizophrenia

AI Analytics
type: Organization